Document Detail


Dexamethasone fails to inhibit the induction of cytosolic phospholipase A(2) expression by interleukin-1beta in cultured primary human amnion fibroblasts.
MedLine Citation:
PMID:  16338461     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the interaction of dexamethasone and interleukin-1beta (IL-1beta) on the expression of cytosolic phospholipase A(2) (cPLA(2)), the enzyme catalyzing the first reaction in the formation of prostaglandins, in cultured primary human amnion fibroblasts. DESIGN AND METHODS: Human amnion fibroblasts were prepared from fetal amnion collected at term and were treated with dexamethasone with or without interleukin-1beta for 24h. Prostaglandin E(2) (PGE(2)) output and cPLA(2) expression in cultured amnion fibroblasts were measured with radioimmunoassay, quantitative real-time polymerase chain reaction, Western blotting and cPLA(2) promoter-driven luciferase reporter gene activity. RESULTS: Both dexamethasone and IL-1beta caused a significant increase in prostaglandin E(2) output, cPLA(2) mRNA and protein expression in cultured human amnion fibroblasts. Both dexamethasone and IL-1beta stimulated cPLA(2) promoter-driven luciferase reporter gene activity. There was no obvious antagonistic or synergistic effect of combined treatment of dexamethasone and IL-1beta on PGE(2) output, cPLA(2) expression or cPLA(2) promoter-driven luciferase reporter gene activity in cultured human amnion fibroblasts. CONCLUSION: The above findings suggest that paradoxically dexamethasone is a stimulator for both prostaglandin synthesis and cPLA(2) expression in human amnion fibroblasts. The interaction between dexamethasone and IL-1beta on prostaglandin synthesis and cPLA(2) expression is neither synergistic nor conventionally antagonistic.
Authors:
K Sun; X Qu; L Gao; L Myatt
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Placenta     Volume:  27     ISSN:  0143-4004     ISO Abbreviation:  Placenta     Publication Date:    2006 Feb-Mar
Date Detail:
Created Date:  2005-12-12     Completed Date:  2006-03-23     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  England    
Other Details:
Languages:  eng     Pagination:  164-70     Citation Subset:  IM    
Affiliation:
Department of Physiology and Biophysics, School of Life Sciences, Fudan University, Second Military Medical University, 220 Handan Road, Shanghai 200433, P.R. China. sunnygangsun@yahoo.com.cn
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amnion / cytology*,  drug effects*,  enzymology
Cells, Cultured
Cytosol / enzymology
Dexamethasone / pharmacology*
Dinoprostone / metabolism
Female
Fibroblasts / drug effects,  enzymology
Genes, Reporter
Humans
Interleukin-1 / pharmacology*
Luciferases / analysis,  genetics
Phospholipases A / antagonists & inhibitors,  genetics,  metabolism*
Promoter Regions, Genetic
Grant Support
ID/Acronym/Agency:
HD31514/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Interleukin-1; 363-24-6/Dinoprostone; 50-02-2/Dexamethasone; EC 1.13.12.-/Luciferases; EC 3.1.1.-/Phospholipases A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Placental NAD(P)H oxidase mediated superoxide generation in early pregnancy.
Next Document:  Corticosterone transfer and metabolism in the dually perfused rat placenta: effect of 11beta-hydroxy...